Table 1.
Patients with MF included in mutation analysis of TP53.
| No. | Gender/age (years) | Clinical stage | Mutation status of TP53 | Disease duration at highest stage |
|---|---|---|---|---|
| 1 | Male/67 | T3N3M1B0 | Mutated: exon 4: c.100C > T (p.P34S); exon 4: c.254C > T (p.P85L); exon 4: c.430C > T (p.Q144stop) | 7 years, DOD |
| 2 | Female/91 | T3N0M0B0 | Mutated: exon 8: c.811G > A (p.E271K); exon 5 and 6 unable to amplify | 1 year, DOD |
| 3 | Female/67 | T4N3M0B2 | No mutations | 10 years, DOD |
| 4 | Male/72 | T3N2M0B0 | No mutations | 2 years, AWD |
| 5 | Female/89 | T3N0M0B0 | No mutations | 8 years, DOC |
| 6 | Female/56 | T4N1M0B1 | No mutations | 5 years, DOD |
| 7 | Male/69 | T3N3M1B0 | No mutations: exon 5 and 6 unable to amplify | 3 years, DOD |
| 8 | Male/76 | T4N3M0B1a | No mutations | 3 years, DOD |
| 9 | Female/65 | T3N1M0B0 | No mutations | 14 years, AWD |
| 10 | Male/83 | T3N0M0B0 | No mutations | 11 years, AWD |
| 11 | Female/55 | T3N0M0B0 | No mutations | 5 years, AWD |
| 12 | Male/75 | T3N0M0B0 | No mutations in exon 7, 10: exon 4, 5, 6, 8, and 9 unable to amplify | 3 years, DOC |
| 13 | Male/64 | T4N3M0B2 | Mutated: exon 5: c.449C > T (p.T150I) | 4 years, DOD |
| 14 | Female/74 | T3N0M0B0 | No mutations | 6 years, AWD |
| 15 | Female/71 | T3N0M0B0 | No mutations | 12 years, AWD |
| 16 | Female/63 | T3N3M0B0 | No mutations: exon 4, 5, and 6 unable to amplify | 5 years, DOC |
| 17 | Male/76 | T3N0M1B0 | Mutated: exon 5: c. 502C > T (p.H168Y); exon 5: c. 530C > A (p.P178H); exon 6: c. 670G > T (p.E224Stop) | 3 years, DOD |
| 18 | Male/99 | T3N0M0B0 | Mutated: exon 8: c.818G > A (p.R273H) | 2 years, DOC |
| 19 | Male/66 | T3N2M0B0 | Mutated: exon 5: c.457C > T (p.P153S); exon 5: c.461G > A (p.G154D) | 5 years, DOD |
AWD, alive with disease; DOD, dead of disease; DOC, dead of other causes.